微载体市场规模和预测、全球和地区份额、趋势以及按产品、设备、应用、最终用户和地理位置进行的成长机会分析
市场调查报告书
商品编码
1389605

微载体市场规模和预测、全球和地区份额、趋势以及按产品、设备、应用、最终用户和地理位置进行的成长机会分析

Microcarriers Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Equipment, Application, End User, and Geography

出版日期: | 出版商: The Insight Partners | 英文 185 Pages | 订单完成后即时交付

价格

根据我们关于「2030 年微载体市场预测 - 全球分析 - 产品、设备、应用和最终用户」的最新研究,该市场预计将从 2022 年的 16.25 亿美元增至 2030 年的 41.78 亿美元。该报告强调推动市场的关键因素和知名参与者的发展。推动市场成长的关键因素是癌症和传染病发病率上升对细胞疗法的需求,以及外包细胞和基因疗法製造的日益普及推动了市场成长。然而,生物製剂和细胞疗法的高成本阻碍了市场成长。

在微载体市场运营的公司专注于策略发展,例如合作、扩张、协议、伙伴关係和新产品发布,这有助于他们提高销售额、扩大地理覆盖范围并增强能力,以满足比现有客户群更大的需求。以下提到了微载体市场的一些值得注意的发展:

2023年10月,可乐丽株式会社开发出用于再生医学细胞培养的PVA水凝胶微载体。该产品计划于 2024 年 1 月在日本和海外推出,首先从美国推出。

2023 年 6 月,帝人前沿推出了新型非织造微载体,可实现快速、大规模、高品质的细胞培养。新型非织造微载体结合了帝人前沿的专有纤维工艺和非织造设计技术,以及日本福井大学工程学院的纤维相关生物医学专业知识。

2023 年 10 月,Semarion 推出了 SemaCyte 微载体平台的早期采用者计画。 Semarion 开发的 SemaCytes 是利用微晶片製造技术、奈米磁性和智慧材料创建的细胞载体材料。这些分析微载体是扁平的,具有超小型磁控孔的功能,可将贴壁细胞的小集落带入悬浮液中,以改善基于细胞的实验。

2022 年 1 月,富士胶片公司宣布计划从 Atara Biotherapeutics, Inc. 收购一家细胞疗法製造工厂。该工厂易于扩展且灵活,可生产临床和商业细胞疗法,包括同种异体 T 细胞和 CAR T 免疫疗法。

2021 年 1 月,赛默飞世尔科技公司收购了 Groupe Novasep SAS 旗下位于比利时的病毒载体製造业 Henogen SA。 Henogen 为生物技术公司和大型生物製药客户提供疫苗和治疗药物製造服务。透过此次收购,赛默飞世尔科技扩大了在细胞和基因疫苗及疗法领域的能力。

因此,推出PVA水凝胶微载体、非织造微载体和SemaCyte微载体平台等产品,并透过合作和伙伴关係启动新业务以维持市场竞争力,将为微载体市场创造重大成长机会。

根据产品,微载体市场分为微载体珠和培养基和试剂。 2022 年,微载体珠细分市场占据最大的市场份额,预计 2022-2030 年CAGR最快,达到 12.8%。不断增长的细胞生物学研究、对再生医学和生物製药的需求以及多家製造商和供应商的存在促成了可观的市场成长。广泛的产品供应和微载体技术的不断发展为主要市场参与者的发展提供了有利可图的机会。 Sartorius AG 等大公司提供不含动物成分和包被蛋白质的微载体珠。

依设备,微载体市场分为生物反应器、培养容器等。 2022年,生物反应器领域占最大的市场份额,预计2022-2030年复合CAGR最快,达到12.8%。生物反应器是进行生物反应的製造装置或容器;它们用于在受控条件下的适当环境中培养酵母、细菌或动物细胞等微生物。它们维持细胞生长和产物形成的支持环境。基于微载体的生物反应器可以即时离线监测细胞生长和品质以及代谢物分析,可用于检测错误并立即纠正。

根据应用,微载体市场分为生物製药生产、细胞和基因治疗、组织工程和再生医学等。 2022年,生物製药生产领域占最大的市场份额,预计2022-2030年复合CAGR最快,达到13.1%。生物製药生产部门进一步细分为治疗药物生产和疫苗生产。微载体是生物製药行业的成熟技术,与搅拌槽生物反应器相结合,可以为贴壁细胞的大规模生产提供必要的环境。用于生产微载体的可生物降解材料具有解决体外疾病模型的能力。微载体在生物製药行业中得到应用,因为它们扩大了可控生物降解的范围。

根据最终用户,微载体市场分为製药和生物技术公司、合约研究组织和合约製造组织(CMO)以及学术和研究机构。到 2022 年,製药和生物技术公司领域占据了最大的市场份额。此外,预计在预测期内该领域的CAGR最高,为 12.9%。製药公司在药品总产量中占有主要份额。药品製造过程通常基于生物技术原理,涉及使用细菌生产胰岛素、人类生长激素等产品。过去十年,製药和生物技术行业取得了广泛增长,这主要归功于研发活动的增加以及引入新微生物产品的监管批准。如此大规模的创新预计将在未来几年推动生物反应器在製药和生物技术製造中的采用,最终有利于製药和生物技术领域的微载体市场成长。

美国食品药物管理局 (USFDA)、临床和经济审查研究所 (ICER)、疾病管制与预防中心 (CDC) 是在准备微载体市场报告时提到的几个关键的主要和次要来源。

目录

第 1 章:简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章:执行摘要

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:微载体市场格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章:微载体市场 - 主要产业动态

  • 主要市场驱动因素:
    • 随着癌症和传染病发病率的上升,对细胞疗法的需求
    • 外包细胞和基因治疗製造越来越受欢迎
  • 市场限制
    • 生物製剂和细胞疗法的高成本
  • 市场机会
    • 微载体製造商的策略性倡议和创新产品
  • 未来的趋势
    • 细胞和基因治疗製造服务的自动化
  • 影响分析

第 6 章:微载体市场 - 全球市场分析

  • 微载体市场收入,2022 - 2030

第 7 章:微载体市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的微载体市场收入份额 (%)
  • 微载体珠
  • 介质和试剂

第 8 章:微载体市场 - 收入和 2030 年预测 - 按设备

  • 概述
  • 2022 年及 2030 年按设备分類的微载体市场收入份额 (%)
  • 生物反应器
  • 培养容器
  • 其他的

第 9 章:微载体市场 - 收入和 2030 年预测 -按应用

  • 概述
  • 2022 年和 2030 年按应用分類的微载体市场收入份额 (%)
  • 生物製药生产
  • 细胞和基因治疗
  • 组织工程与再生医学
  • 其他的

第 10 章:微载体市场收入和 2030 年预测 - 最终用户

  • 概述
  • 按最终用户分類的全球微载体市场份额 - 2022 年和 2030 年 (%)
  • 製药和生物技术公司
    • 概述
  • 合约研究组织和合约製造组织
    • 概述
  • 学术及研究机构
    • 概述

第 11 章:微载体市场收入和 2028 年预测 - 地理分析

  • 北美洲
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章:微载体市场-产业格局

  • 概述
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章:公司简介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第 14 章:附录

  • 关于 Insight Partners
  • 专业术语
Product Code: TIPBT00002183

According to our latest study on "Microcarriers Market Forecast to 2030 - Global Analysis -Product, Equipment, Application, and End User," the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights the key factors driving the market and prominent players with their developments. Key factors driving the market growth are need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned below:

In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.

In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

In January 2022, FUJIFILM Corporation announced its plan to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category.

Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Based on product, the microcarriers market is divided into microcarrier beads and media & reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.

Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. They maintain a supportable environment for cell growth and product formation. A microcarrier-based bioreactor allows real-time off-line monitoring of cell growth and quality and metabolite analyses, which can be utilised to detect errors and rectify them immediately.

Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022-2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Based on end user, the microcarriers market is segmented pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations (CMOs), and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. Moreover, the same is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, etc., products. The pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade mainly owing to increased R&D activities and regulatory approvals for the introduction of new microbe-based products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth for the pharmaceutical and biotechnological segment.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), Centers for Disease Control and Prevention (CDC), are a few key primary and secondary sources referred to while preparing the report on the microcarriers market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Microcarriers Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Microcarriers Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Microcarriers Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Microcarriers Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Biologics and Cell-based Therapies
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 5.4 Future Trends
    • 5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 5.5 Impact Analysis

6. Microcarriers Market - Global Market Analysis

  • 6.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

7. Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Microcarrier Beads
    • 7.3.1 Overview
    • 7.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Media and Reagents
    • 7.4.1 Overview
    • 7.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 8.3 Bioreactors
    • 8.3.1 Overview
    • 8.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Culture Vessels
    • 8.4.1 Overview
    • 8.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Biopharmaceutical Production
    • 9.3.1 Overview
    • 9.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cell and Gene Therapy
    • 9.4.1 Overview
    • 9.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Tissue Engineering and Regenerative Medicine
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

10. Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 10.1 Overview
  • 10.2 Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 10.4.1 Overview
    • 10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Academic and Research Institutes
    • 10.5.1 Overview
    • 10.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

11. Microcarriers Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 11.1 North America Microcarriers Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: Microcarriers Market, by Product
    • 11.1.4 North America: Microcarriers Market, by Equipment
    • 11.1.5 North America: Microcarriers Market, by Application
      • 11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
    • 11.1.6 North America: Microcarriers Market, by End User
    • 11.1.7 North America: Microcarriers Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.3 US: Microcarriers Market, by Product
        • 11.1.7.1.4 US: Microcarriers Market, by Equipment
        • 11.1.7.1.5 US: Microcarriers Market, by Application
        • 11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.1.6 US: Microcarriers Market, by End User
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.3 Canada: Microcarriers Market, by Product
        • 11.1.7.2.4 Canada: Microcarriers Market, by Equipment
        • 11.1.7.2.5 Canada: Microcarriers Market, by Application
        • 11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.2.6 Canada: Microcarriers Market, by End User
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.3 Mexico: Microcarriers Market, by Product
        • 11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
        • 11.1.7.3.5 Mexico: Microcarriers Market, by Application
        • 11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.3.6 Mexico: Microcarriers Market, by End User
  • 11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: Microcarriers Market, by Product
    • 11.2.4 Europe: Microcarriers Market, by Equipment
    • 11.2.5 Europe: Microcarriers Market, by Application
      • 11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
    • 11.2.6 Europe: Microcarriers Market, by End User
    • 11.2.7 Europe: Microcarriers Market, by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 11.2.7.1.3 Germany: Microcarriers Market, by Product
        • 11.2.7.1.4 Germany: Microcarriers Market, by Equipment
        • 11.2.7.1.5 Germany: Microcarriers Market, by Application
        • 11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.1.6 Germany: Microcarriers Market, by End User
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK: Microcarriers Market, by Product
        • 11.2.7.2.4 UK: Microcarriers Market, by Equipment
        • 11.2.7.2.5 UK: Microcarriers Market, by Application
        • 11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.2.6 UK: Microcarriers Market, by End User
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France: Microcarriers Market, by Product
        • 11.2.7.3.4 France: Microcarriers Market, by Equipment
        • 11.2.7.3.5 France: Microcarriers Market, by Application
        • 11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.3.6 France: Microcarriers Market, by End User
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 11.2.7.4.3 Italy: Microcarriers Market, by Product
        • 11.2.7.4.4 Italy: Microcarriers Market, by Equipment
        • 11.2.7.4.5 Italy: Microcarriers Market, by Application
        • 11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.4.6 Italy: Microcarriers Market, by End User
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain: Microcarriers Market, by Product
        • 11.2.7.5.4 Spain: Microcarriers Market, by Equipment
        • 11.2.7.5.5 Spain: Microcarriers Market, by Application
        • 11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.5.6 Spain: Microcarriers Market, by End User
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
        • 11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
        • 11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
  • 11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: Microcarriers Market, by Product
    • 11.3.4 Asia Pacific: Microcarriers Market, by Equipment
    • 11.3.5 Asia Pacific: Microcarriers Market, by Application
      • 11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
    • 11.3.6 Asia Pacific: Microcarriers Market, by End User
    • 11.3.7 Asia Pacific: Microcarriers Market, by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 11.3.7.1.3 China: Microcarriers Market, by Product
        • 11.3.7.1.4 China: Microcarriers Market, by Equipment
        • 11.3.7.1.5 China: Microcarriers Market, by Application
        • 11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.1.6 China: Microcarriers Market, by End User
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.3 Japan: Microcarriers Market, by Product
        • 11.3.7.2.4 Japan: Microcarriers Market, by Equipment
        • 11.3.7.2.5 Japan: Microcarriers Market, by Application
        • 11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.2.6 Japan: Microcarriers Market, by End User
      • 11.3.7.3 India
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.3 India: Microcarriers Market, by Product
        • 11.3.7.3.4 India: Microcarriers Market, by Equipment
        • 11.3.7.3.5 India: Microcarriers Market, by Application
        • 11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.3.6 India: Microcarriers Market, by End User
      • 11.3.7.4 Australia
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.3.7.4.3 Australia: Microcarriers Market, by Product
        • 11.3.7.4.4 Australia: Microcarriers Market, by Equipment
        • 11.3.7.4.5 Australia: Microcarriers Market, by Application
        • 11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.4.6 Australia: Microcarriers Market, by End User
      • 11.3.7.5 South Korea
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.3 South Korea: Microcarriers Market, by Product
        • 11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
        • 11.3.7.5.5 South Korea: Microcarriers Market, by Application
        • 11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.5.6 South Korea: Microcarriers Market, by End User
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
  • 11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: Microcarriers Market, by Product
    • 11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
    • 11.4.5 Middle East & Africa: Microcarriers Market, by Application
      • 11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
    • 11.4.6 Middle East & Africa: Microcarriers Market, by End User
    • 11.4.7 Middle East & Africa: Microcarriers Market, by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
        • 11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
        • 11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
        • 11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
        • 11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
      • 11.4.7.2 South Africa
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.3 South Africa: Microcarriers Market, by Product
        • 11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
        • 11.4.7.2.5 South Africa: Microcarriers Market, by Application
        • 11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.2.6 South Africa: Microcarriers Market, by End User
      • 11.4.7.3 UAE
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.3 UAE: Microcarriers Market, by Product
        • 11.4.7.3.4 UAE: Microcarriers Market, by Equipment
        • 11.4.7.3.5 UAE: Microcarriers Market, by Application
        • 11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.3.6 UAE: Microcarriers Market, by End User
      • 11.4.7.4 Rest Middle East & Africa
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
        • 11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
        • 11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
        • 11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
  • 11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: Microcarriers Market, by Product
    • 11.5.4 South & Central America: Microcarriers Market, by Equipment
    • 11.5.5 South & Central America: Microcarriers Market, by Application
      • 11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
    • 11.5.6 South & Central America: Microcarriers Market, by End User
    • 11.5.7 South & Central America: Microcarriers Market, by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
        • 11.5.7.1.3 Brazil: Microcarriers Market, by Product
        • 11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
        • 11.5.7.1.5 Brazil: Microcarriers Market, by Application
        • 11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.1.6 Brazil: Microcarriers Market, by End User
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina: Microcarriers Market, by Product
        • 11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
        • 11.5.7.2.5 Argentina: Microcarriers Market, by Application
        • 11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.2.6 Argentina: Microcarriers Market, by End User
      • 11.5.7.3 Rest Of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
        • 11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
        • 11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
        • 11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User

12. Microcarriers Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 Teijin Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Bio-Rad Laboratories Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 denovoMATRIX GmbH
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Corning Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Eppendorf SE
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Percell Biolytica AB
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Asahi Kasei Corp
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Polysciences Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. North America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. North America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. North America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. North America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. North America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. US Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. US Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. US Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. US Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. Canada Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Canada Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. Canada Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. Canada Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Mexico Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Mexico Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Mexico Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Mexico Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 33. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 34. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 35. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 36. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 37. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 38. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 39. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 40. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 41. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 42. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 43. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 44. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 45. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 46. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 47. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 48. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 49. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 50. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 51. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 52. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 53. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 54. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 55. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 56. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 57. Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 58. Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 59. Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 60. Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 61. Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 62. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 63. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 64. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 65. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 66. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 67. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 68. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 69. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 70. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 71. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 72. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 73. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 74. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 75. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 76. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 77. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 78. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 79. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 80. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 81. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 82. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 83. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 84. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 85. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 86. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 87. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 88. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 89. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 90. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 91. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 92. Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 93. Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 94. Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 95. Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 96. Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 97. Saudi Arabia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 98. Saudi Arabia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 99. Saudi Arabia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 100. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 101. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 102. South Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 103. South Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 104. South Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 105. South Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 106. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 107. UAE Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 108. UAE Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 109. UAE Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 110. UAE Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 111. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 112. Rest Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 113. Rest Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 114. Rest Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 115. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 116. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 117. South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 118. South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 119. South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 120. South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 121. South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 122. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 123. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 124. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 125. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 127. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 128. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 129. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 130. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 131. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 132. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 133. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 134. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 135. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 136. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 137. Recent Organic Growth Strategies in Microcarriers Market
  • Table 138. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 139. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Region
  • Figure 2. Key Insights
  • Figure 3. Global - PEST Analysis
  • Figure 4. Microcarriers Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 6. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 7. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 11. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 22. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 25. Microcarriers Market, 2022 ($Mn)
  • Figure 26. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 28. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Microcarriers Market, 2022 ($Mn)
  • Figure 32. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
  • Figure 35. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
  • Figure 38. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Microcarriers Market, 2022 ($Mn)
  • Figure 41. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 43. China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
  • Figure 44. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 47. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Microcarriers Market, 2022 ($Mn)
  • Figure 50. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 52. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
  • Figure 53. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 56. Microcarriers Market, 2022 ($Mn)
  • Figure 57. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 59. Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
  • Figure 60. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)